Targacept starts new trial for diabetes drug
Bizjournals.com Targacept will take a drug it hopes will become a treatment for asthma and Type 2 diabetes into a Phase 2 clinical trial, the company has announced. … Targacept to begin phase 2 trials for its anti-inflammatory drug compound TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and … |
View full post on asthma – Google News